IGFBP-2 - taking the lead in growth, metabolism and cancer

[1]  B. Cui,et al.  Morphological and transcriptional responses of Lycopersicon esculentum to hexavalent chromium in agricultural soil , 2016, Environmental toxicology and chemistry.

[2]  D. Ahlquist,et al.  Colorectal Adenomas. , 2016, The New England journal of medicine.

[3]  G. Werther,et al.  IGFBP-2 - taking the lead in growth, metabolism and cancer , 2015, Journal of Cell Communication and Signaling.

[4]  F. Dunshea,et al.  IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes , 2014, International Journal of Obesity.

[5]  D. Clemmons,et al.  IGFBP‐2 Directly Stimulates Osteoblast Differentiation , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Kejiang Li,et al.  Is insulin-like growth factor binding protein 2 associated with metastasis in lung cancer? , 2014, Clinical & Experimental Metastasis.

[7]  G. McConell,et al.  Leptin enhances insulin sensitivity by direct and sympathetic nervous system regulation of muscle IGFBP-2 expression: evidence from nonrodent models. , 2014, Endocrinology.

[8]  S. Teo,et al.  Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer. , 2014, American journal of clinical pathology.

[9]  G. Werther,et al.  IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells , 2014, Oncogene.

[10]  T. Thompson,et al.  Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches , 2013, Oncogene.

[11]  G. Mills,et al.  Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  Xifeng Wu,et al.  Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival , 2013, PloS one.

[13]  L. Maile,et al.  The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice. , 2013, Endocrinology.

[14]  A. Ben-Ze'ev,et al.  Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression , 2013, Oncogene.

[15]  Mel Greaves,et al.  Acute lymphoblastic leukaemia , 2013, The Lancet.

[16]  S. Meshinchi,et al.  Children's Oncology Group's 2013 blueprint for research: Acute myeloid leukemia , 2013, Pediatric blood & cancer.

[17]  L. Zeng,et al.  Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor. , 2013, Endocrinology.

[18]  L. Lo Nigro,et al.  Biology of Childhood Acute Lymphoblastic Leukemia , 2013, Journal of pediatric hematology/oncology.

[19]  Richard Aplenc,et al.  Epidemiology of childhood acute myeloid leukemia , 2013, Pediatric blood & cancer.

[20]  E. Estey,et al.  Acute myeloid leukemia: 2013 update on risk‐stratification and management , 2013, American journal of hematology.

[21]  J. Hernández-Rivas,et al.  Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease. , 2013, Cancer genetics.

[22]  O. Nedić,et al.  Interaction of Insulin-Like Growth Factor-Binding Protein 2 with α2-Macroglobulin in the Circulation , 2013, The Protein Journal.

[23]  Qing Zhu,et al.  Autoantibodies against insulin-like growth factor-binding protein-2 as a serological biomarker in the diagnosis of lung cancer , 2012, International journal of oncology.

[24]  A. Smerieri,et al.  Interactions among pro-inflammatory cytokines, IGF system and thyroid function in pre-pubertal obese subjects. , 2013, Journal of biological regulators and homeostatic agents.

[25]  H. Kantarjian,et al.  Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management , 2012, American journal of hematology.

[26]  L. Maile,et al.  Insulin-Like Growth Factor (IGF) Binding Protein 2 Functions Coordinately with Receptor Protein Tyrosine Phosphatase β and the IGF-I Receptor To Regulate IGF-I-Stimulated Signaling , 2012, Molecular and Cellular Biology.

[27]  Konrad Basler,et al.  The many faces and functions of β‐catenin , 2012, The EMBO journal.

[28]  Mohammed Shanshal,et al.  Chronic lymphocytic leukemia. , 2012, Disease-a-month : DM.

[29]  R. Norton,et al.  Insulin-like growth factor binding protein-2: NMR analysis and structural characterization of the N-terminal domain. , 2012, Biochimie.

[30]  L. Maile,et al.  Insulin‐like growth factor‐binding protein‐2 is required for osteoclast differentiation , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  優花 竹之内.  Insulin-Like Growth Factor-Binding Protein 2 , 2012 .

[32]  J. Ko,et al.  Influence of catch-up growth on IGFBP-2 levels and association between IGFBP-2 and cardiovascular risk factors in Korean children born SGA. , 2012, Endocrine journal.

[33]  K. Basler,et al.  Focus Review The many faces and functions of b-catenin , 2012 .

[34]  W. Carroll,et al.  Clinical and laboratory biology of childhood acute lymphoblastic leukemia. , 2012, The Journal of pediatrics.

[35]  A. Smerieri,et al.  Effects of Cord Serum Insulin, IGF-II, IGFBP-2, IL-6 and Cortisol Concentrations on Human Birth Weight and Length: Pilot Study , 2011, PloS one.

[36]  P. Hillmen.  Using the biology of chronic lymphocytic leukemia to choose treatment. , 2011, Hematology. American Society of Hematology. Education Program.

[37]  C. Bloomfield,et al.  High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia. , 2011, Leukemia research.

[38]  F. Dunshea,et al.  Dietary Monounsaturated Fat in Early Life Regulates IGFBP2: Implications for Fat Mass Accretion and Insulin Sensitivity , 2011, Obesity.

[39]  J. Rowley,et al.  Chronic myeloid leukemia: current perspectives. , 2011, Clinics in laboratory medicine.

[40]  A. Hoffman,et al.  IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells. , 2011, Endocrinology.

[41]  K. Brismar,et al.  Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1, -2 and -4. , 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[42]  W. Kiess,et al.  IGFBP-2 at the interface of growth and metabolism--implications for childhood obesity. , 2011, Pediatric endocrinology reviews : PER.

[43]  D. Larhammar,et al.  Evolution of the insulin-like growth factor binding protein (IGFBP) family. , 2011, Endocrinology.

[44]  D. Gillatt,et al.  Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel , 2011, British Journal of Cancer.

[45]  M. Bouxsein,et al.  The Heparin-binding Domain of IGFBP-2 Has Insulin-like Growth Factor Binding-independent Biologic Activity in the Growing Skeleton* , 2011, The Journal of Biological Chemistry.

[46]  Bonadonna Riccardo,et al.  Adipocytes IGFBP‐2 Expression in Prepubertal Obese Children , 2010, Obesity.

[47]  M. Waters,et al.  Patched1 Inhibits Epidermal Progenitor Cell Expansion and Basal Cell Carcinoma Formation by Limiting Igfbp2 Activity , 2010, Cancer Prevention Research.

[48]  F. Picard,et al.  Modulation of IGFBP2 mRNA expression in white adipose tissue upon aging and obesity. , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[49]  A. Hoeflich,et al.  Increased fat mass, decreased myofiber size, and a shift to glycolytic muscle metabolism in adolescent male transgenic mice overexpressing IGFBP-2. , 2010, American journal of physiology. Endocrinology and metabolism.

[50]  G. Fuller,et al.  JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration. , 2010, International journal of oncology.

[51]  Hsiu‐Po Wang,et al.  Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer. , 2010, The Journal of clinical endocrinology and metabolism.

[52]  Y. Ishikawa,et al.  Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3. , 2010, The American journal of pathology.

[53]  M. Pollak,et al.  IGFBP‐2 Expression in MCF‐7 Cells is Regulated by the PI3K/AKT/mTOR Pathway through Sp1 Induced Increase in Transcription , 2010, Growth factors.

[54]  A. Hokken-Koelega,et al.  Serum insulin-like growth factor-binding protein-2 levels and metabolic and cardiovascular risk factors in young adults and children born small for gestational age. , 2010, The Journal of clinical endocrinology and metabolism.

[55]  R. Wysocki,et al.  Antidiabetic effects of IGFBP2, a leptin-regulated gene. , 2010, Cell metabolism.

[56]  G. Fuller,et al.  IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas , 2009, Proceedings of the National Academy of Sciences.

[57]  Takashi Takahashi,et al.  Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer. , 2009, The American journal of pathology.

[58]  G. Werther,et al.  Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells. , 2009, Endocrine-related cancer.

[59]  A. Hoeflich,et al.  IGFBP‐2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis , 2009, International journal of cancer.

[60]  H. Ariga,et al.  PAPA-1 Is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions. , 2009, Molecular endocrinology.

[61]  R. Sikes,et al.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions. , 2009, American journal of translational research.

[62]  A. Hoeflich,et al.  Defined carboxy-terminal fragments of insulin-like growth factor (IGF) binding protein-2 exert similar mitogenic activity on cultured rat growth plate chondrocytes as IGF-I. , 2008, Endocrinology.

[63]  S. Khatua,et al.  IGFBP2 Is Overexpressed by Pediatric Malignant Astrocytomas and Induces the Repair Enzyme DNA-PK , 2008, Journal of Child Neurology.

[64]  M. Bouxsein,et al.  Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. , 2008, Endocrinology.

[65]  G. Fuller,et al.  IGFBP2 and IGFBP5 Overexpression Correlates With the Lymph Node Metastasis in T1 Breast Carcinomas , 2008, The breast journal.

[66]  S. Li,et al.  A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import. , 2008, Endocrinology.

[67]  D. Steinbach,et al.  Expression of components of the IGF axis in childhood acute myelogenous leukemia , 2008, Pediatric blood & cancer.

[68]  M. Ueffing,et al.  Functional Proteomics , 2008, Methods in Molecular Biology.

[69]  Hiroaki Kataoka,et al.  Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma. , 2007, Anticancer research.

[70]  L. Rejtõ,et al.  Hormonal regulation of IGFBP‐2 proteolysis is attenuated with progression to androgen insensitivity in the LNCaP progression model , 2007, Journal of cellular physiology.

[71]  C. Perks,et al.  IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells , 2007, Oncogene.

[72]  R. Baxter,et al.  The in Vivo Phosphorylation and Glycosylation of Human Insulin-like Growth Factor-binding Protein-5 *S , 2007, Molecular & Cellular Proteomics.

[73]  S. Nakano,et al.  Silencing of Insulin-like Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both Invasiveness and Expression of Progression-associated Gene CD24* , 2007, Journal of Biological Chemistry.

[74]  R. Baxter,et al.  Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. , 2007, Endocrinology.

[75]  K. Yano,et al.  Matrix metalloproteinase‐7 triggers the matricrine action of insulin‐like growth factor‐II via proteinase activity on insulin‐like growth factor binding protein 2 in the extracellular matrix , 2007, Cancer science.

[76]  S. Horvath,et al.  Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer , 2007, Proceedings of the National Academy of Sciences.

[77]  Antonio Vidal-Puig,et al.  IGF-Binding Protein-2 Protects Against the Development of Obesity and Insulin Resistance , 2007, Diabetes.

[78]  M. Krawczuk-Rybak,et al.  Are elevated serum levels of IGFBP-2 after intensive chemotherapy of childhood acute lymphoblastic leukemia a risk factor of relapse? , 2007, Advances in medical sciences.

[79]  R. Norton,et al.  Structure, dynamics and heparin binding of the C-terminal domain of insulin-like growth factor-binding protein-2 (IGFBP-2). , 2006, Journal of molecular biology.

[80]  S. Mohan,et al.  Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo. , 2006, Endocrinology.

[81]  T. Burns,et al.  Insulin-like growth factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signaling , 2006, Cancer biology & therapy.

[82]  G. Fuller,et al.  Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types , 2006, Modern Pathology.

[83]  A. Hoeflich,et al.  IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. , 2006, Journal of molecular endocrinology.

[84]  A. Lykkesfeldt,et al.  Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator. , 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[85]  S. Anderson,et al.  Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[86]  B. Gruhn,et al.  Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML , 2006, Bone Marrow Transplantation.

[87]  A. Suminoe,et al.  IDENTIFICATION OF NOVEL GENES WITH PROGNOSTIC VALUE IN CHILDHOOD LEUKEMIA USING cDNA MICROARRAY AND QUANTITATIVE RT-PCR , 2006, Pediatric hematology and oncology.

[88]  S. Corroyer,et al.  Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibition. , 2005, The Biochemical journal.

[89]  C. Dealy,et al.  Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth. , 2005, Bone.

[90]  M. Georgescu,et al.  PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2. , 2005, Biochemical and biophysical research communications.

[91]  A. Hoeflich,et al.  Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. , 2005, Endocrinology.

[92]  W. Blum,et al.  Insulin-like growth factor binding protein-2 at diagnosis of childhood acute lymphoblastic leukemia and the prediction of relapse risk. , 2005, The Journal of clinical endocrinology and metabolism.

[93]  Tadashi Kondo,et al.  Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic β-catenin protein , 2005, Oncogene.

[94]  Thomas Braulke,et al.  Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern. , 2005, Biochemistry.

[95]  W. Blum,et al.  Serum levels of insulin-like growth factor-I,-II and insulin-like growth factor binding proteins-2 and-3 in children with acute lymphoblastic leukaemia , 1996, European Journal of Pediatrics.

[96]  I. Shmulevich,et al.  Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion , 2005, Molecular Cancer.

[97]  A. Hoeflich,et al.  Peri/nuclear localization of intact insulin-like growth factor binding protein-2 and a distinct carboxyl-terminal IGFBP-2 fragment in vivo. , 2004, Biochemical and biophysical research communications.

[98]  M. Overgaard,et al.  Proteolytic degradation of IGF-binding protein (IGFBP)-2 in equine ovarian follicles: involvement of pregnancy-associated plasma protein-A (PAPP-A) and association with dominant but not subordinated follicles. , 2004, The Journal of endocrinology.

[99]  G. Rao,et al.  Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice , 2004, Oncogene.

[100]  D. Newgreen,et al.  Fibroblast growth factor‐2 over‐rides insulin‐like growth factor‐I induced proliferation and cell survival in human neuroblastoma cells , 2004, Journal of cellular physiology.

[101]  M. Elmlinger,et al.  Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. , 2004, Journal of molecular endocrinology.

[102]  E. Gazzerro,et al.  Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts. , 2004, American journal of physiology. Endocrinology and metabolism.

[103]  C. Heinlein,et al.  Androgen receptor in prostate cancer. , 2004, Endocrine reviews.

[104]  Joseph J. Pereira,et al.  Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with αvβ3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth 1 , 2004, Cancer Research.

[105]  L. Sepp-Lorenzino.  Structure and function of the insulin-like growth factor I receptor , 1998, Breast Cancer Research and Treatment.

[106]  J. Heinrich,et al.  Differential Impact of Simple Childhood Obesity on the Components of the Growth Hormone-Insulin-like Growth Factor (IGF)-IGF Binding Proteins Axis , 2004, Journal of pediatric endocrinology & metabolism : JPEM.

[107]  G. Fuller,et al.  IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[108]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[109]  G. Krassas.  Endocrine abnormalities in Anorexia Nervosa. , 2003, Pediatric endocrinology reviews : PER.

[110]  G. Fuller,et al.  Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. , 2003, Cancer research.

[111]  F. Zintl,et al.  Changes of serum growth factors (IGF-I,-II and IGFBP-2,-3) prior to and after stem cell transplantation in children with acute leukemia , 2003, Bone Marrow Transplantation.

[112]  T. Bek,et al.  The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[113]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[114]  A. Hoeflich,et al.  Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic mice , 2002, Anatomy and Embryology.

[115]  S. Khosla,et al.  Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. , 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[116]  M. Rechler,et al.  Insulin‐like growth factor binding protein‐2 mediates the inhibition of DNA synthesis by transforming growth factor‐β in mink lung epithelial cells * † , 2002, Journal of cellular physiology.

[117]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[118]  A. Hoeflich,et al.  Growth Inhibition in Giant Growth Hormone Transgenic Mice by Overexpression of Insulin-Like Growth Factor-Binding Protein-2. , 2001, Endocrinology.

[119]  S. Bustin,et al.  Increased levels of insulin‐like growth factor binding protein‐2 in sera and tumours from patients with colonic neoplasia with and without acromegaly , 2001, Clinical endocrinology.

[120]  Y. Maru.  Molecular Biology of Chronic Myeloid Leukemia , 2001, International journal of hematology.

[121]  E. Nabeyrat,et al.  Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells. , 2001, Biochimica et biophysica acta.

[122]  J. Argente,et al.  Insulin-Like Growth Factor-Binding Protein-2 Levels in Pediatric Patients with Growth Hormone Deficiency, Eating Disorders and Acute Lymphoblastic Leukemia , 2000, Hormone Research in Paediatrics.

[123]  T. Wood,et al.  Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. , 2000, Molecular endocrinology.

[124]  C. Potten,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Circulating Insulin-Like Growth Factor II and , 2000 .

[125]  R. Baxter,et al.  Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin β Subunit* , 2000, The Journal of Biological Chemistry.

[126]  J Straub,et al.  APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[127]  M. Hotta,et al.  The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. , 2000, The Journal of clinical endocrinology and metabolism.

[128]  R. Baxter,et al.  A Central Domain Binding Site in Insulin-Like Growth Factor Binding Protein-5 for the Acid-Labile Subunit. , 2000, Endocrinology.

[129]  J. Frystyk,et al.  Circulating levels of free insulin‐like growth factors in obese subjects: the impact of Type 2 diabetes , 1999, Diabetes/metabolism research and reviews.

[130]  G. Semenza,et al.  Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. , 1999, Cancer research.

[131]  S. J. Kim,et al.  Serum insulin-like growth factor (IGF)-I and IGF-binding proteins in lung cancer patients. , 1999, Journal of Korean medical science.

[132]  G. Werther,et al.  Basic fibroblast growth factor induces proteolysis of secreted and cell membrane-associated insulin-like growth factor binding protein-2 in human neuroblastoma cells. , 1999, Endocrinology.

[133]  C. Lang,et al.  Alterations in the Growth Hormone-Insulin-Like Growth Factor Axis in Insulin Dependent Diabetes Mellitus , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[134]  A. Hoeflich,et al.  Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. , 1999, Endocrinology.

[135]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[136]  T. Braulke.  Type-2 IGF Receptor: A Multi-Ligand Binding Protein , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[137]  A. Sidawy,et al.  Role of insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding protein-2 in human colorectal cancers. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[138]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[139]  E. Wolf,et al.  Insulin‐like growth factor‐binding protein‐2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF‐responsive colon carcinoma cell lines , 1998, FEBS letters.

[140]  W. Blum,et al.  Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone. , 1998, British Journal of Cancer.

[141]  A. Burgess,et al.  Growth control mechanisms in normal and transformed intestinal cells. , 1998, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[142]  A. Hoeflich,et al.  Altered growth of mice divergently selected for body weight is associated with complex changes in the growth hormone/insulin-like growth factor system. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[143]  M. Elmlinger,et al.  Elevated insulin-like growth factor (IGF) binding protein (IGFBP)-2 and IGFBP-4 expression of leukemic T-cells is affected by autocrine/paracrine IGF-II action but not by IGF type I receptor expression. , 1998, European journal of endocrinology.

[144]  J. Wallace,et al.  Localization of an Insulin-like Growth Factor (IGF) Binding Site of Bovine IGF Binding Protein-2 Using Disulfide Mapping and Deletion Mutation Analysis of the C-terminal Domain* , 1998, The Journal of Biological Chemistry.

[145]  D. Halliday,et al.  Changes in protein turnover, IGF‐I and IGF binding proteins in children with cancer , 1998, Acta paediatrica.

[146]  R. Baxter,et al.  Characterization of truncated insulin-like growth factor-binding protein-2 in human milk. , 1997, Endocrinology.

[147]  Y. Song,et al.  Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone , 1997, International Journal of Obesity.

[148]  R. Baxter,et al.  Phosphorylation of insulin-like growth factor binding proteins , 1997, Molecular and Cellular Endocrinology.

[149]  R. Baxter,et al.  Insulin‐like growth factor‐binding protein‐2 in patients with prostate carcinoma and benign prostatic hyperplasia , 1997, Clinical endocrinology.

[150]  M. Langman,et al.  Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. , 1997, British Journal of Cancer.

[151]  M. Elmlinger,et al.  Insulin-like growth factor binding protein 2 is differentially expressed in leukaemic B- and T-cell lines. , 1996, Growth regulation.

[152]  A. Karasik,et al.  Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid. , 1996, British Journal of Cancer.

[153]  D. Clemmons,et al.  Substitution of Specific Amino Acids in Insulin-like Growth Factor (IGF) Binding Protein 5 Alters Heparin Binding and Its Change in Affinity for IGF-I in Response to Heparin (*) , 1996, The Journal of Biological Chemistry.

[154]  S. Mohan,et al.  Insulin‐Like Growth Factor (IGF) System Components in Human Prostatic Cancer Cell‐Lines: LNCaP, DU145, and PC‐3 Cells , 1996, International journal of urology : official journal of the Japanese Urological Association.

[155]  E Ruoslahti,et al.  RGD and other recognition sequences for integrins. , 1996, Annual review of cell and developmental biology.

[156]  T. Wood,et al.  Genetic approaches to the function of insulin-like growth factor-binding proteins during rodent development. , 1996, Hormone research.

[157]  J. Thrasher,et al.  Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. , 1996, The Journal of clinical endocrinology and metabolism.

[158]  K. Iwasaki,et al.  Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. , 1996, The Journal of clinical endocrinology and metabolism.

[159]  K. Tatemoto,et al.  Synthesis and secretion of insulin-like growth factor (IGF)-II and IGF binding protein-2 by cultivated brain meningeal cells , 1995, Brain Research.

[160]  M. Corkins,et al.  Growth stimulation by transfection of intestinal epithelial cells with an antisense insulin-like growth factor binding protein-2 construct. , 1995, Biochemical and biophysical research communications.

[161]  C. Bondy,et al.  Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis. , 1995, Endocrinology.

[162]  L. Giudice,et al.  Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. , 1995, The Journal of clinical endocrinology and metabolism.

[163]  G. Werther,et al.  Cell membrane association of insulin-like growth factor binding protein-2 (IGFBP-2) in the rat brain olfactory bulb. , 1995, Progress in growth factor research.

[164]  K. Shitara,et al.  Brain-specific receptor-type protein-tyrosine phosphatase RPTP beta is a chondroitin sulfate proteoglycan in vivo. , 1994, The Journal of biological chemistry.

[165]  F. Garrouste,et al.  Alterations in serum levels of insulin‐like growth factors and insulin‐like growth‐factor‐binding proteins in patients with colorectal cancer , 1994, International journal of cancer.

[166]  S. Sallan,et al.  Biology and therapy of childhood acute lymphoblastic leukemia. , 1994, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[167]  A. Karasik,et al.  Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. , 1994, The Journal of clinical endocrinology and metabolism.

[168]  K. Siddle,et al.  Hybrid and atypical insulin/insulin-like growth factor I receptors. , 1994, Hormone research.

[169]  D. Clemmons,et al.  The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis. , 1993, The Journal of clinical endocrinology and metabolism.

[170]  N. Bleehen,et al.  Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. , 1993, Cancer research.

[171]  D. DiGregorio,et al.  Growth factor modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cells. , 1993, Endocrinology.

[172]  T. Stamey,et al.  Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. , 1993, The Journal of clinical endocrinology and metabolism.

[173]  M. Waters,et al.  of Insulin-Like Growth , 1993 .

[174]  L. Carlsson,et al.  The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. , 1992, The Journal of clinical endocrinology and metabolism.

[175]  J. G. Reeve,et al.  Insulin‐like growth‐factor‐binding protein gene expression and protein production by human tumour cell lines , 1992, International journal of cancer.

[176]  N. Bleehen,et al.  Expression of insulinlike growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines. , 1992, Journal of the National Cancer Institute.

[177]  J. Gordon,et al.  The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system , 1992, The Journal of cell biology.

[178]  R. Vigneri,et al.  High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells. , 1992, The Journal of clinical investigation.

[179]  G. Jaques,et al.  Differential expression of insulin-like growth factor binding proteins in human non-small cell lung cancer cell lines. , 1992, European journal of cancer.

[180]  J. Perdue,et al.  The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor. , 1991, The Journal of biological chemistry.

[181]  L. Giudice,et al.  Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. , 1990, The Journal of clinical endocrinology and metabolism.

[182]  R. Humbel,et al.  Insulin-like growth factors I and II. , 1990, European journal of biochemistry.

[183]  V. Duronio,et al.  Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. , 1989, The Journal of biological chemistry.

[184]  D. Chelsky,et al.  Sequence requirements for synthetic peptide-mediated translocation to the nucleus , 1989, Molecular and cellular biology.

[185]  P. Rotwein,et al.  Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. , 1989, Endocrine reviews.

[186]  K. Hall,et al.  Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. , 1988, Acta endocrinologica.

[187]  V. Han,et al.  Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. , 1987, Science.

[188]  G. Bell,et al.  Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. , 1987, Endocrinology.

[189]  E. Froesch,et al.  Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. , 1986, Hormone research.